Andrew HubermanBest Tools for Gut Health & Weight Loss | Dr. Chris Thompson
Andrew Huberman
Feeding the Gut Microbiome 0:00
You need to feed your gut microbes, and what they eat is fiber. If you do not give them enough fiber, they start eating your mucous layer instead, the thin barrier that protects your gut wall. When that happens, they stop producing enough butyrate, a substance your body needs to maintain the tight junctions that hold your gut lining together. This creates a snowball effect, so neglecting fiber and the microbiome can lead to a cascade of problems.
Introducing Dr Chris Thompson 0:31
Andrew Huberman introduces Dr Chris Thompson, a professor of medicine at Harvard Medical School and chief of interventional gastroenterology at Mass General Brigham in Boston. Thompson is described as an expert on the intersection of gastroenterology, metabolism, nutrition, and obesity medicine, credited with helping create an entire new field of treatments in this area. The episode promises a clear picture of how the gastrointestinal system works along with modern, evidence based tools for gut health.
How the Digestive Tube Works 3:00
The gut is compartmentalized, with each section doing a distinct job. The esophagus simply moves food safely down into the stomach, and problems there include swallowing difficulty and a condition called achalasia, where the bottom of the esophagus fails to relax, which can be treated by tunneling into the esophagus layers to cut the muscle. The stomach first stretches to accept a meal, sometimes triggered just by the smell of food, then mechanically grinds it down using acid before slowly releasing it into the duodenum. The stomach also secretes ghrelin, a hormone tied to satiety signaling, and problems like gastroparesis, sometimes triggered by a virus or diabetes, can prevent the stomach from emptying properly, causing nausea and vomiting.
Small Bowel and Colon Roles 7:00
The small bowel's main job is absorbing calories, and its lining is only one cell thick, made of sturdy columnar epithelium cells, yet it covers a surface area about the size of a pickleball court. Goblet cells produce mucin to build a protective layer, and tight junctions between cells add further protection, alongside immune cells. Diseases like celiac disease and Crohn's disease affect this region, and the small bowel is now understood to play a central role in metabolic disease, including obesity and diabetes. The colon's main job is absorbing water, but it works closely with the microbiome, which produces short chain fatty acids, especially butyrate, that affect metabolism and satiety, and the colon also produces a lot of GLP-1.
Colon Cancer Screening 9:01
Colon cancer is the most frequent cancer type Thompson sees in his field, and survival rates are improving thanks to screening programs. The recommended screening age has moved to 45, and people with a family history should start ten years before the age their relative was diagnosed. Options include stool based genetic tests like Cologuard, done every few years, or a colonoscopy every ten years if results are normal. New techniques now allow doctors to remove very early cancers endoscopically, an organ sparing approach that lets patients keep their colon and go home the same day.
Food Going Up the Nose 13:31
When food seems to travel up the nose during eating, this can stem from an oropharyngeal transfer problem, where swallowing coordination breaks down, sometimes treatable through speech pathology training. It can also come from high tension in the upper esophageal sphincter, sometimes linked to Zenker's diverticula, small pockets that form near that sphincter and trap food. These pockets can be corrected through a minor incision made through the mouth, and treating them matters because trapped food can be aspirated into the lungs, leading to scarring over time.
Reading Your Bowel Movements 18:00
Bowel movements offer a lot of information about health. The general rule is no more than three a day and no longer than three days between movements, ideally producing one well formed stool. Small hard pellets, called scybalous stool, signal a problem, often insufficient fiber, a concern the World Health Organization highlighted when it found most people, especially in Western countries, do not get enough fiber. Dark, tarry, shiny stool can indicate blood in the GI tract. The commonly cited daily fiber targets are 35 grams for men and 25 grams for women, though this varies by body size.
Fiber, Fasting, and the Gut 18:30
Recent studies show resistant starch, such as raw powdered potato taken at around 40 grams, significantly improved fatty liver and, in clamp studies, improved insulin sensitivity, showing fiber's benefits go well beyond regularity. Huberman shares that adding powdered psyllium husk to his diet made him feel better after meals rather than bloated, challenging the common assumption that more fiber means more gas and bloating. On intermittent fasting, Thompson notes that while fasting periods can cause the microbiome to consume the digestive tract lining, the rebound afterward tends to leave things better off, and he sees the metabolic benefits of time restricted eating, such as allowing insulin to come down, as outweighing this risk.
Fermented Foods and Gut Diversity 23:30
You bring up a study by Justin Sonnenberg and colleagues comparing low-sugar fermented foods, like kimchi, sauerkraut, and brine pickles, against fiber. Dr. Thompson explains that the fermented foods group showed a reclaimed diversity in the microbiome and reduced inflammatory markers, something the fiber group did not show. He notes that fermented foods act as both prebiotic, feeding the microbiome partially digested material, and probiotic, since they carry live cultures such as bifidobacteria and lactobacillus. These foods help bacteria crossfeed, with one group breaking down fiber into acetate and lactate, which other bacteria then convert into butyrate. Butyrate feeds colon cells, supports the tight junctions that keep the gut barrier intact, and plays a role in GLP-1 and satiety pathways. Fermented foods also keep the bowel acidic, which protects against pathogenic organisms that thrive in less acidic environments. Dr. Thompson says he personally drinks kefir and recommends kimchi, sauerkraut, yogurt, and kombucha as staples missing from the typical Western diet.
Ulcers, Stress, and H. Pylori 27:01
The conversation turns to canker sores and ulcers, and the long-held belief that stress or mouth wounds caused them before Barry Marshall won a Nobel Prize for identifying H. pylori as a bacterial cause of gastric ulcers, a finding he proved by infecting himself. H. pylori has even been found in the stomach of Ötzi, the five-thousand-year-old iceman found frozen in the Italian Alps, showing how long the bacterium has been with humans. But Dr. Thompson, drawing on his own research in gastric bypass patients, says ulcers are not purely infectious. He found cases caused by relative ischemia, reduced blood flow linked to type two diabetes or smoking, and in gastric bypass patients specifically, a lack of bicarbonate reaching the rerouted small bowel meant no way to neutralize stomach acid. Stress can still increase acid production, so multiple factors, not one single cause, usually contribute to ulcers.
GLP-1 Drugs and Adherence 30:00
Shifting to metabolic health, Dr. Thompson says he is grateful GLP-1 drugs exist because obesity had gone largely untreated before them. Still, adherence is a major issue: over a million people a month come off GLP-1s, about thirty percent within the first month and fifty percent within a year, a dropout pattern similar to blood pressure or cholesterol medications. Reasons include needle fatigue, difficulty remembering daily oral doses, nausea from ramping up to effective doses, muscle loss, and uncertainty about long-term effects of taking a super-physiologic dose. In his own endoscopic therapy practice, over eighty-five percent of patients have already tried a GLP-1 and either struggled with it or stopped.
Microdosing GLP-1 Medications 33:31
Dr. Thompson describes learning about microdosing from a physician-patient who diluted his GLP-1 pen into a sterile vial and used an insulin syringe to take smaller doses, avoiding nausea while keeping his weight stable. He now recommends this approach to many patients: reach the dose needed to lose weight, then shift to a maintenance microdose rather than stopping outright. Stopping entirely is risky because roughly a third of weight lost on drugs like semaglutide is lean muscle mass; cycling on and off means people regain fat without regaining muscle, worsening body composition with each cycle. Resistance training, he notes, helps preserve muscle during weight loss on any method, not just GLP-1s.
Side Effects and Patient Complaints 37:31
Some reported side effects, like reduced food noise, apathy, or lowered appetite for alcohol and life generally, circulate widely on social media but aren't necessarily well documented. A rare but real risk is a form of optic nerve ischemia that can cause blindness in a very small subset of users, so screening matters, though it's not a widespread danger. When patients tell Dr. Thompson why they stopped, the most common reasons are muscle loss, sometimes subtle like a flattened face or buttocks, sometimes true sarcopenia in people who weren't exercising, and nausea at higher doses needed for weight loss.
History of Weight Loss Surgery 40:02
Dr. Thompson traces bariatric surgery back to the 1950s at the University of Minnesota, starting with the jejunoileal bypass, a malabsorption procedure that created a long blind limb of unused small bowel, leading to bacterial overgrowth and kidney failure from oxalate binding calcium in the body instead of the gut. This was replaced in the mid-to-late 1960s by gastric bypass, developed by a surgeon named Mason, intended to combine restriction and malabsorption, though it turns out the mechanism works differently than originally theorized. Later procedures, including adjustable lap bands and the sleeve gastrectomy, were built on similar restriction-based reasoning even though their real effects differ from the original concepts.
Surgical Innovation and Regulation 42:32
Asked whether the huge personal and professional incentive to develop a named, life-saving procedure ever pushes surgeons past what's safe, Dr. Thompson says the proper regulatory channels are generally workable, and compassionate use pathways exist for urgent cases, citing an instance where he got twelve-hour approval to use a device approved in Canada but not yet in the United States for a patient with uncontrollable bleeding. He also describes routine off-label use, such as using wires approved for vascular procedures to remove bile duct stones, a practice that has become standard without ever being formally approved for that purpose. He notes regulatory feedback can even improve study design, such as suggesting additional gut hormone measurements.
The Hunger and Fullness Hormones 47:30
The conversation lists the major gut hormones behind appetite. Ghrelin, the hunger hormone, is made in the fundus, the thin upper part of the stomach near where the esophagus enters, and it rises to make you feel hungry, then drops once you eat. Insulin actually ticks up slightly even before eating, triggered by smell or sight of food, alongside a stretching of the stomach in anticipation of a meal. After food leaves the stomach, CCK rises from the duodenum, prompting the gallbladder to release bile while also signaling fullness. Peptide YY and GLP-1 follow, along with GIP, a hormone similar to GLP-1 but less potent, often described as GLP-1's sidekick. The new drug tirzepatide combines GLP-1, GIP, and glucagon, and Lily's trial data showed about a 30 percent reduction in body weight. GIP appears to reduce nausea, allowing higher GLP-1 doses, while glucagon's main job is burning fat and may help preserve muscle.
Why Obesity Drugs Struggled Before 51:31
Twenty years ago there was little available for obesity beyond stimulant-based drugs like phentermine, essentially a sympathomimetic similar to speed, with known risks like heart valve issues. Nicotine has resurged in oral form as an appetite suppressant, especially among men, despite raising blood pressure and being highly addictive. A Bethesda NIH study is cited where subjects ate either whole foods or processed foods; those eating processed foods consumed about 500 more calories a day, since such food is easier to digest, causes bigger glucose spikes, and produces a lower thermogenic effect, while also lacking fiber that supports the microbiome.
Leptin's Rise and Disappointment 54:01
Leptin, secreted from fat cells, acts like a thermostat tied to fat stores, generally suppressing appetite when high. Once discovered and cloned, it was expected to lead to major obesity treatments, but leptin resistance developed in people with long-term obesity, where the hypothalamus stops responding, worsened by low-grade inflammation, so the anticipated drugs never panned out.
The History Behind Incretin Discovery 55:30
The concept of incretins traces back to 1930s London, where researchers injected ground-up animal duodenum into animals and found it lowered blood glucose, leading to the discovery of secretin and the coining of "incretin." Later, Sheila Sherlock's lab showed that oral glucose produced far more insulin than intravenous glucose of the same amount, naming this the incretin effect. Eventually, a researcher named Bell cloned pre-proglucagon, yielding GLP-1 and GLP-2, and a London physician named Blossom confirmed GLP-1 raised insulin and lowered glucose, though it broke down too fast to use as a drug. In the 1990s in the Bronx, Dr. Eng studied Gila monster venom and found a similar molecule, resistant to breakdown, which became the basis for GLP-1 drugs.
Building a Better Diagnostic Needle 59:30
Dr. Thompson describes training in interventional gastroenterology in Boston, learning endoscopic ultrasound to diagnose pancreatic conditions through the mouth rather than surgery. His mentor gave him a poorly performing biopsy needle, designed like an IV needle rather than one meant to extract tissue, yielding only a fifty-fifty diagnostic success rate for pancreatic cancer. Years later, working with engineers, he helped redesign the needle's bevel to safely capture tissue without causing pancreatitis, improving early cancer diagnosis and preserving cellular structure well enough for precision medicine testing.
Toward Less Invasive Screening 1:04:00
The discussion turns to whether minimally invasive, near-painless biopsies of every major organ could become routine, similar to how blood tests for hormones and cholesterol became cheap and common. Dr. Thompson agrees procedure-based diagnosis needs to become less invasive to scale, since one-on-one procedures limit how many patients can be reached, and argues technology, smartphones, AI, and blood tests should catch metabolic problems far earlier.
The Sequence of Metabolic Decline 1:07:30
Metabolic dysregulation follows a predictable order, starting with calorie excess, mainly glucose, which a continuous glucose monitor can reveal through post-meal spikes. The Whitehall II study of British civil servants showed high fasting insulin predicted diabetes up to fifteen years later, yet fasting insulin is rarely checked. The NHANES data showed only about a third of lean people, roughly twelve percent of the whole population, are truly metabolically healthy by measures like waist circumference, glucose, and blood pressure. As insulin stays chronically elevated from frequent eating and high-glycemic foods, fat begins accumulating abnormally as ectopic fat, meaning fat stored inside liver, muscle, or pancreas cells that aren't meant to store it, unlike the healthier subcutaneous, visceral, or organ-associated fat.
The path from fat gain to disease 1:12:02
Dr. Thompson lays out a step by step sequence of metabolic decline backed by clinical studies. It starts with fat building up in muscle and liver, described using the comparison to overfed, unmoving Wagyu cattle. Fatty liver is flagged as especially dangerous. You can check this stage with a waist circumference or waist to height ratio, a DEXA scan for visceral fat, a CT or MRI, or a simple liver enzyme test called ALT. The next stage is insulin resistance, measured by multiplying fasting glucose and fasting insulin and dividing by a constant, with a result above two signaling trouble.
Losing metabolic flexibility 1:13:30
The final stage is metabolic inflexibility, where the body stops switching properly between burning fat while fasting and burning carbs after eating. Instead it burns glycogen or even muscle, and studies show this stage predicts future weight gain, obesity, and burnout of insulin producing beta cells. This can be measured with a breath test tracking the ratio of carbon dioxide to oxygen, since burning carbs needs less oxygen than burning fat. Some companies are now building at home versions of this breath test, though most people simply wait until a standard glucose or A1C test shows a problem.
Sponsor message for Function 1:15:30
The hosts pause for a sponsor break describing Function, a service offering over 160 lab tests covering heart, hormone, autoimmune, and nutrient health, along with MRI and CT access. Huberman shares that testing revealed slightly high blood lipids, which he addressed by supplementing with nattokinase, later confirming improvement on a follow up test. Membership costs about a dollar a day.
Physician resistance to patient data 1:17:31
Huberman describes pushback from parts of the medical community against patients accessing their own data, whether through CGMs or whole body MRI and scans like Prenuvo. He notes a case where such a scan reportedly caught a malignant issue early in a celebrity. He points out that CGM resistance has faded over the past couple of years as more people simply use them briefly to see how foods, exercise, or poor sleep affect their blood sugar.
Why early data beats waiting 1:20:01
Dr. Thompson explains that medicine moves slowly because it demands multiple randomized trials and meta analyses before change, even for elective procedures that carry no obligation. He argues that once someone already has diabetes, nerve damage, or lost beta cell mass, treatment is far less effective, so waiting for perfect data denies people a chance to act early using tools like fasting insulin or a CGM to learn how their body responds to food.
Slow adoption, then AI powered surgery 1:24:01
Both note that doctors resist new procedures partly because mastering them takes a year or more, not a weekend course, drawing a comparison to mechanics adapting slowly to computerized cars. Dr. Thompson describes AI now coaching surgeons in real time through a heads up display, highlighting structures, guiding stitch placement, counting sutures, and grading procedure quality. Robotics have already shortened learning curves for trainees and once helped mediocre surgeons perform near expert level, and he expects layering AI onto robotics could push outcomes further, with AI trained on thousands of procedures used to inform judgment rather than to operate on its own.
AI and Advanced Imaging in Endoscopy 1:35:00
Dr. Thompson explains that AI pattern recognition can now highlight blood vessels during procedures like endoscopic ultrasound, which normally appear only as shades of gray, reducing the risk of accidentally hitting them. He describes his own earlier attempts to overlay CT or PET scans onto ultrasound images to better locate tumors, work that once took three hours of setup and could not scale, but which AI is now making nearly automatic. He also points to hyperspectral imaging, where narrow bands of light wavelengths reveal a kind of tissue fingerprint, letting surgeons see tumor margins without injecting dye, using advances in LED and camera chip technology.
Sponsor Break: Our Place Cookware 1:37:00
Dr. Thompson pauses to acknowledge the sponsor Our Place, noting that many nonstick pans contain PFAS or forever chemicals linked to hormone disruption, gut microbiome damage, and fertility problems. He highlights the Titanium Always Pan Pro, made with pure titanium and no coating, as a nonstick option free of these toxins.
From Crude Tools to Targeted Physiology 1:39:01
The conversation turns to how medicine gathers information, from what comes out of the body, to skin and eye appearance, to blood tests and imaging like X-rays, all aimed at getting more information with less invasive procedures. Dr. Thompson is asked whether a quick scan could someday replace blood tests for finding tumors, and he says he is hopeful but uncertain, pointing instead to real progress in understanding physiology well enough to target it directly. He contrasts treating a pathology, like cutting out a tumor, with augmenting normal physiology, which is what GLP-1 drugs do by raising levels far beyond anything the body naturally produces in response to a meal.
Discovering the Gut Hormone Connection 1:42:30
Dr. Thompson recounts a pivotal case from 2003 or 2004, when a gastric bypass patient developed a fistula between the small new stomach pouch and the old stomach, causing reflux, weight regain, and returning diabetes. Using a new suturing device, he closed the fistula, expecting only to fix the reflux, but the patient also lost weight and their diabetes resolved almost immediately, a result that pushed him to study gut hormones seriously. He connects this to related work, including a colleague's rat studies showing that excluding the foregut, specifically the duodenum, improved diabetes far more than rerouting food to the hindgut, and to older human studies from the 1980s showing that healthy people have a strong insulin response to oral versus intravenous glucose that diabetics lack, tied to incretins like GLP-1.
Devices and Procedures Built on Foregut Exclusion 1:47:30
Building on these findings, Dr. Thompson describes closing fistulas in more patients, finding that 60 percent achieved diabetes resolution when the foregut exclusion was restored, compared to none when it wasn't. This led device companies to develop an endoscopic duodenal liner, a sleeve implant that separates food from digestive enzymes for a few feet, producing a one point drop in A1C and about 7 percent weight loss, though it must eventually be removed. A separate approach, ileal interposition surgery, moved GLP-1-dense distal small bowel up near the duodenum in lean diabetic patients, reversing diabetes without any weight loss or malabsorption. This inspired a nonsurgical method of simply ablating the duodenum, which also lowers A1C by over a point and may help prevent weight regain after stopping GLP-1 drugs by allowing the duodenum's stem cells to regenerate into a healthier state.
Overfeeding, Inflammation, and Tight Junctions 1:51:01
Dr. Thompson describes studies showing that overfed mice develop longer, heavier intestines with longer villi, adapting to absorb more calories, and that similar changes appear in humans with obesity or type two diabetes, including eightfold higher natural killer cell activity and 1.5-fold higher macrophage levels. He explains that this adaptation comes at a cost, since the energy used for bowel changes leaves tight junction proteins, the scaffolding that keeps the gut lining sealed, deprioritized and disorganized.
Is Leaky Gut Real 1:53:32
Asked whether leaky gut is a legitimate medical concept, Dr. Thompson says increased gut permeability is absolutely real, but the popular term carries vague or exaggerated connotations that make doctors wary. He cites a recent study using bile biopsies and lab-grown organoids showing that patients with MASH, a metabolically associated fatty liver condition, had poorly developed, disorganized tight junctions and were not even producing the RNA needed to make tight junction proteins. Another study using a tracer called chromium EDTA found it leaked into the bloodstream in MASH patients but not in healthy people or treated celiac patients, showing that bacterial products like LPS can pass through, trigger inflammatory pathways such as NF-kB signaling, and, as shown in a Duke study injecting LPS into healthy volunteers, spike inflammatory markers and induce insulin resistance. He ties this back to the importance of fiber, fermented foods, and a healthy microbiome, since gut bacteria producing butyrate are essential for maintaining healthy tight junctions and a protective mucin layer.
Artificial Sweeteners and Fructose 1:58:30
Dr. Thompson says artificial sweeteners are better than high fructose corn syrup, and he thinks about them the way he thinks about alcohol, something to use sparingly rather than avoid entirely. He is not worried about fructose from whole fruit, since it arrives wrapped in a food matrix that slows absorption, unlike a sugary drink, which floods the liver rapidly and forces it to process a burst of fructose all at once. He notes that fruit juice, being minimally processed, behaves more like whole fruit, while the real problem with artificial sweeteners is that they usually appear inside heavily processed foods, making it hard to separate the sweetener's effect from the effect of everything else in the product.
Seed Oils and the Avocado Oil Scandal 2:02:31
He defends polyunsaturated fats as generally safe and even beneficial for lowering LDL cholesterol, arguing the foods they're bundled in, not the fats themselves, are usually the problem. He mentions a recent UC Davis analysis that found many avocado oil products actually contain none of the oil they advertise. He calls the seed oil versus lard debate exaggerated, comparing it to professional wrestling, and says his own approach is simple: olive oil as the clear favorite, with small amounts of butter, since no one seriously disputes olive oil's benefits. He adds that problems with polyunsaturated fats mostly arise from oxidized oil sitting too long or from repeated deep frying that generates trans fats.
Omega-3s and Supplementation Philosophy 2:03:31
He eats fatty fish a couple of times a week and says the data on omega-3s for metabolic and cardiovascular health is mixed, though they seem more clearly useful for early Alzheimer's symptoms. His general philosophy is that supplementing should follow a detected deficiency rather than happen universally, the same logic he applies to vitamin D. He points out that fish themselves just consolidate omega-3s from algae, so vegetarians can get the same benefit directly from algae-based sources.
Set Point and Why Weight Loss Reverses 2:06:32
He explains that the body defends a weight range rather than a fixed point, shaped by leptin, thyroid hormones, and other signals. After a crash diet, like the pattern seen in Biggest Loser contestants, the body fights back on several fronts at once: a smaller body burns fewer calories, muscles become roughly 25 percent more efficient at the same tasks, satiety hormones like GLP-1, PYY, and CCK drop, and ghrelin rises sharply, all while resting metabolic rate falls. A follow-up NIH study on former Biggest Loser contestants found they were burning about 500 fewer calories a day afterward, which is why diet and exercise alone so often fail to hold weight off long term.
Targeting Ghrelin and Gut Hormones with Procedures 2:08:30
He describes the ESG procedure he developed in 2012, which folds the stomach through an endoscope to create a smaller pocket that stretches faster, sending fullness signals to the brain, while also keeping food in the stomach longer to suppress ghrelin. Because ghrelin stays suppressed, patients keep weight off more easily for ten years or longer. A newer refinement ablates ghrelin-producing cells in the stomach's fundus using tools like argon plasma coagulation, pushing weight loss from about 18 percent with ESG alone toward 25 percent. He also describes a magnetic anastomosis technique, developed with a partner and tested in the Czech Republic, that connects the jejunum to the ileum using ring magnets delivered by endoscope, triggering large GLP-1 spikes and replicating much of what gastric bypass achieves, without the original open surgery's risks.
Combining Levers Instead of Pushing One Hard 2:15:30
He and his guest draw a parallel between these multi-target procedures and drugs like retatrutide, which nudges GLP-1, GIP, and glucagon systems together rather than maxing out one pathway, producing better weight loss with muscle sparing and fewer side effects. He agrees that combining smaller interventions, whether procedures plus drugs or lower doses of each, spreads risk more safely than pushing hard on any single lever. He stresses that even after a procedure or a GLP-1 drug, patients still need to fix the fundamentals, more fiber, better diet, avoiding insulin spikes, and regular exercise, because studies like Look AHEAD show that diet and exercise alone produced only about six percent weight loss at ten years with no cardiovascular benefit, since the body's countermeasures go unaddressed otherwise.
Gene Therapy for Nutrient-Responsive GLP-1 2:17:01
He describes an early-stage gene therapy he helped develop, using a viral vector carrying the GLP-1 gene paired with the beta cell insulin promoter, so that GLP-1 is secreted together with insulin in a nutrient-responsive way, directly from the pancreas rather than from distant L cells. The vector is delivered by endoscopic ultrasound injection into the tail of the pancreas, with animal studies confirming it stays localized and activates only in beta cells, not alpha cells. Because pancreatic cells are terminally differentiated and don't turn over like gut lining does, the injected DNA can persist and keep transcribing without needing repeated dosing. The therapy has just entered clinical trials in the Netherlands, and in mouse trials, animals given the transgene lost slightly more weight than those given high-dose semaglutide, then plateaued rather than continuing to lose weight indefinitely. He suggests this approach could eventually help conditions like Prader-Willi syndrome, where hyperphagia driven by missing hypothalamic signals doesn't respond well to standard GLP-1 drugs.
Trans Gene Weight Regain Data 2:22:00
The discussion touches once more on the study results, noting that animals given the trans gene returned to the same weight settling point, a positive outcome, while those randomized to receive nothing regained all the weight they had lost, underscoring the potential of this approach for weight loss.
A Lifelong Tinkerer 2:22:31
Dr. Chris Thompson explains that he has always been someone who builds and fixes things with his hands, recalling taking apart a motorcycle in high school that he could not reassemble and fixing car parts that later caught fire. This hands-on nature shaped his career choice, pushing him away from general internal medicine, which he felt often just manages a slow decline by prescribing medications for high blood pressure or LDL without addressing root causes, and toward fields like interventional gastroenterology where he could solve underlying problems directly.
Gratitude and Team Effort 2:24:30
The host thanks Thompson for his compassion toward patients and his willingness to share knowledge publicly, calling the drive to think about better solutions the mark of an excellent physician, scientist, or engineer. Thompson responds that innovation is never the work of one person but always a team effort, crediting the colleagues who have helped move the work forward, and the conversation closes with mutual thanks and an invitation to return once further progress has been made.
AI-generated summary. It can be wrong or incomplete - check anything that matters against the original.
